Delphine Borgniet

Delphine’s practice covers all areas of intellectual property law with a focus on the life science sector as well as pharmaceutical regulatory law. She advises clients, mostly pharmaceutical, medical device and biotech companies from the innovative industry, on a broad range of matters relating to regulatory affairs (including MA procedures, parallel import, pricing-reimbursement, clinical trials, early access programs, compliance and advertising issues).

She works on different (cross-border) matters relating to market access strategy for complex medicinal products as well as to late life-cycle management through patent enforcement in regulatory matters. She is also involved in several proceedings before the Belgian (administrative) courts against decisions by the Belgian state on parallel import authorisation grant and pricing and/or reimbursement decisions.